1 San Francisco Veterans Affairs Medical Center, San Francisco, California.
2 Department of Medicine, University of California at San Francisco, San Francisco, California.
Am J Respir Crit Care Med. 2018 May 15;197(10):1319-1327. doi: 10.1164/rccm.201708-1613OC.
Acute respiratory effects of low-level ozone exposure are not well defined in older adults.
MOSES (The Multicenter Ozone Study in Older Subjects), although primarily focused on acute cardiovascular effects, provided an opportunity to assess respiratory responses to low concentrations of ozone in older healthy adults.
We performed a randomized crossover, controlled exposure study of 87 healthy adults (59.9 ± 4.5 yr old; 60% female) to 0, 70, and 120 ppb ozone for 3 hours with intermittent exercise. Outcome measures included spirometry, sputum markers of airway inflammation, and plasma club cell protein-16 (CC16), a marker of airway epithelial injury. The effects of ozone exposure on these outcomes were evaluated with mixed-effect linear models. A P value less than 0.01 was chosen a priori to define statistical significance.
The mean (95% confidence interval) FEV and FVC increased from preexposure values by 2.7% (2.0-3.4) and 2.1% (1.3-2.9), respectively, 15 minutes after exposure to filtered air (0 ppb). Exposure to ozone reduced these increases in a concentration-dependent manner. After 120-ppb exposure, FEV and FVC decreased by 1.7% (1.1-2.3) and 0.8% (0.3-1.3), respectively. A similar concentration-dependent pattern was still discernible 22 hours after exposure. At 4 hours after exposure, plasma CC16 increased from preexposure levels in an ozone concentration-dependent manner. Sputum neutrophils obtained 22 hours after exposure showed a marginally significant increase in a concentration-dependent manner (P = 0.012), but proinflammatory cytokines (IL-6, IL-8, and tumor necrosis factor-α) were not significantly affected.
Exposure to ozone at near ambient levels induced lung function effects, airway injury, and airway inflammation in older healthy adults. Clinical trial registered with www.clinicaltrials.gov (NCT01487005).
低浓度臭氧暴露对老年人的急性呼吸道影响尚未明确。
MOSES(多中心老年Subjects 臭氧研究)主要关注急性心血管效应,但也提供了一个机会,以评估低浓度臭氧对健康老年人的呼吸道反应。
我们对 87 名健康成年人(59.9±4.5 岁;60%为女性)进行了一项随机交叉、对照暴露研究,分别暴露于 0、70 和 120 ppb 臭氧 3 小时,并间歇性运动。结果测量包括肺活量测定、气道炎症的痰标志物和血浆 club 细胞蛋白-16(CC16),这是气道上皮损伤的标志物。使用混合效应线性模型评估臭氧暴露对这些结果的影响。预先选择 P 值小于 0.01 来定义统计学意义。
暴露于过滤空气(0 ppb)后 15 分钟,FEV 和 FVC 分别从预暴露值增加 2.7%(2.0-3.4)和 2.1%(1.3-2.9)。臭氧暴露以浓度依赖的方式降低了这些增加。暴露于 120-ppb 后,FEV 和 FVC 分别降低 1.7%(1.1-2.3)和 0.8%(0.3-1.3)。暴露后 22 小时仍能识别出类似的浓度依赖性模式。暴露后 4 小时,血浆 CC16 以浓度依赖的方式从预暴露水平增加。暴露后 22 小时获得的痰中性粒细胞以浓度依赖的方式呈轻微显著增加(P=0.012),但促炎细胞因子(IL-6、IL-8 和肿瘤坏死因子-α)没有受到显著影响。
在接近环境水平下暴露于臭氧会引起健康老年人的肺功能效应、气道损伤和气道炎症。临床试验在 www.clinicaltrials.gov 注册(NCT01487005)。